Clinkenbeard, E.
Segregating the effects of ferric citrate-mediated iron utilization and FGF23 in a mouse model of CKD
Liesen, Michael P., Agoro, R., Swallow, E., Noonan, M., Ni, P., Damrath, J., Wallace, J., Clinkenbeard, E., Allen, M., White, K. , and Hum, Julia
Ferric citrate (FC) is an approved therapy for chronic kidney disease (CKD) pa- tients as a phosphate (Pi) binder for dialysis-dependent CKD, and for iron de- ficiency anemia (IDA) in non-dialysis CKD. Elevated Pi and IDA...
Article
Work1
Article1
Agoro, R.1
Allen, M.1
Clinkenbeard, E.[remove]1
Damrath, J.1
Hum, Julia1
CKD1
GF231
ferric citrate1
iron1
kidney1
English1
The Physiological Society1
20221
Faculty Publications and Research - MUCOM1
Student Publications and Research - MUCOM1
Marian University1